|
1
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism, and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zeng H, Zhang Z, Dai X, Chen Y, Ye J and
Jin Z: Increased expression of microRNA-199b-5p associates with
poor prognosis through promoting cell proliferation, invasion and
migration abilities of human osteosarcoma. Pathol Oncol Res.
22:253–260. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fang C, Zhao Y and Guo B: MiR-199b-5p
targets HER2 in breast cancer cells. J Cell Biochem. 114:1457–1463.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Fang C, Wang FB, Li Y and Zeng XT:
Down-regulation of miR-199b-5p is correlated with poor prognosis
for breast cancer patients. Biomed Pharmacother. 84:1189–1193.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wu X, Weng L, Li X, Guo C, Pal SK, Jin JM,
Li Y, Nelson RA, Mu B, Onami SH, et al: Identification of a
4-microRNA signature for clear cell renal cell carcinoma metastasis
and prognosis. PLoS One. 7:e356612012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Favreau AJ, McGlauflin RE, Duarte CW and
Sathyanarayana P: miR-199b, a novel tumor suppressor miRNA in acute
myeloid leukemia with prognostic implications. Exp Hematol Oncol.
5:42016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang C, Song B, Song W, Liu J, Sun A, Wu
D, Yu H, Lian J, Chen L and Han J: Underexpressed microRNA-199b-5p
targets hypoxia-inducible factor-1α in hepatocellular carcinoma and
predicts prognosis of hepatocellular carcinoma patients. J
Gastroenterol Hepatol. 26:1630–1637. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Navrátil J, Fabian P, Palácová M,
Petráková K, Vyzula R and Svoboda M: Triple negative breast cancer.
Klin Onkol. 28:405–415. 2015.(In Czech). View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yoshimura T, Matsuyama W and Kamohara H:
Discoidin domain receptor 1: A new class of receptor regulating
leukocyte-collagen interaction. Immunol Res. 31:219–230. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Turashvili G, Bouchal J, Baumforth K, Wei
W, Dziechciarkova M, Ehrmann J, Klein J, Fridman E, Skarda J,
Srovnal J, et al: Novel markers for differentiation of lobular and
ductal invasive breast carcinomas by laser microdissection and
microarray analysis. BMC Cancer. 7:552007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Neuhaus B, Bühren S, Böck B, Alves F,
Vogel WF and Kiefer F: Migration inhibition of mammary epithelial
cells by Sky is blocked in the presence of DDR1 receptors. Cell Mol
Life Sci. 68:3757–3770. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Quan J, Yahata T, Adachi S, Yoshihara K
and Tanaka K: Identification of receptor tyrosine kinase, discoidin
domain receptor 1 (DDRl), as a potential biomarker for serous
ovarian cancer. Int J Mol Sci. 12:971–982. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Colas E, Perez C, Cabrera S, Pedrola N,
Monge M, Castellvi J, Eyzaguirre F, Gregorio J, Ruiz A, Llaurado M,
et al: Molecular markers of endometrial carcinoma detected in
uterine aspirates. Int J Cancer. 129:2435–2444. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Nemoto T, Ohashi K, Akashi T, Johnson JD
and Hirokawa K: Overexpression of protein tyrosine kinases in human
esophageal cancer. Pathobiology. 65:195–203. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Valencia K, Ormazábal C, Zandueta C,
Luis-Ravelo D, Antón I, Pajares MJ, Agorreta J, Montuenga LM,
Martínez-Canarias S, Leitinger B and Lecanda F: Inhibition of
collagen receptor discoidin domain receptor-1 (DDR1) reduces cell
survival, homing, and colonization in lung cancer bone metastasis.
Clin Cancer Res. 18:969–980. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Das S, Ongusaha PP, Yang YS, Park JM,
Aaronson SA and Lee SW: Discoidin domain receptor 1 receptor
tyrosine kinase induces cyclooxygenase-2 and promotes
chemoresistance through nuclear factor-kappaB pathway activation.
Cancer Res. 66:8123–8130. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Park HS, Kim KR, Lee HJ, Choi HN, Kim DK,
Kim BT and Moon WS: Overexpression of discoidin domain receptor 1
increases the migration and invasion of hepatocellular carcinoma
cells in association with matrix metalloproteinase. Oncol Rep.
18:1435–1441. 2007.PubMed/NCBI
|
|
18
|
Ram R, Lorente G, Nikolich K, Urfer R,
Foehr E and Nagavarapu U: Discoidin domain receptor-1a (DDR1a)
promotes glioma cell invasion and adhesion in association with
matrix metalloproteinase-2. J Neurooncol. 76:239–248. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Shen Q, Cicinnati VR, Zhang X, Iacob S,
Weber F, Sotiropoulos GC, Radtke A, Lu M, Paul A, Gerken G and
Beckebaum S: Role of microRNA-199a-5p and discoidin domain receptor
1 in human hepatocellular carcinoma invasion. Mol Cancer.
9:2272010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Toy KA, Valiathan RR, Núñez F, Kidwell KM,
Gonzalez ME, Fridman R and Kleer CG: Tyrosine kinase discoidin
domain receptors DDR1 and DDR2 are coordinately deregulated in
triple-negative breast cancer. Breast Cancer Res Treat. 150:9–18.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Duncan JS, Whittle MC, Nakamura K, Abell
AN, Midland AA, Zawistowski JS, Johnson NL, Granger DA, Jordan NV,
Darr DB, et al: Dynamic reprogramming of the kinome in response to
targeted MEK inhibition in triple-negative breast cancer. Cell.
149:307–321. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Marcotte R, Brown KR, Suarez F, Sayad A,
Karamboulas K, Krzyzanowski PM, Sircoulomb F, Medrano M, Fedyshyn
Y, Koh JLY, et al: Essential gene profiles in breast, pancreatic,
and ovarian cancer cells. Cancer Discov. 2:172–189. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Chalmin F, Ladoire S, Mignot G, Vincent J,
Bruchard M, Remy-Martin JP, Boireau W, Rouleau A, Simon B, Lanneau
D, et al: Membrane-associated Hsp72 from tumor-derived exosomes
mediates STAT3-dependent immunosuppressive function of mouse and
human myeloid-derived suppressor cells. J Clin Invest. 120:457–471.
2010.PubMed/NCBI
|
|
25
|
Ebert MS and Sharp PA: MicroRNA sponges:
Progresss and possibilities. RNA. 16:2043–2050. 2010. View Article : Google Scholar : PubMed/NCBI
|
